EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Extramedullary Disease with Bone Marrow Necrosis at Disease Onset in A Case of Mixed Phenotypic Acute Leukemia with BCR::ABL1 Fusion Gene: a Case Report and Review of the Literature

Yutaka Shimazu, Takashi Miyoshi, Satoko Mibayashi, Yasuhiro Kazuma, Miyako Kobayashi, Keisuke Shindo, Shinsaku Imashuku

Oncology Advances · 2023

DOI: 10.14218/ona.2023.00022 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Oncology Advances, 2023. Verfasst von Yutaka Shimazu und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mixed phenotype acute leukemia (MPAL) is an uncommon acute leukemia, representing only 2–5% of acute leukemia cases. Extramedullary disease (EMD) is typically seen during a relapse or with disease progression. When EMD occurs in acute myeloid leukemia, it is called myeloid sarcoma. However, to the best of our knowledge, there are no reports of EMD in MPAL patients at the initial diagnosis. We provide the first case, which shows EMD associated with bone marrow necrosis of MPAL with minor BCR/ABL (BCR::ABL1 fusion gene) at disease onset. A 50-year-old Japanese man presented to a hematologist with a month-long history of immobility due to severe lumbar pain. Bone marrow aspirations were unsuccessful. Computed tomography revealed a mass in the left iliopsoas muscle and hepatosplenomegaly. He was diagnosed with MPAL associated with minor BCR/ABL, and EMD was confirmed by the analysis of blast phenotype in peripheral blood and necrotic bone marrow, as well as the biopsied mass in the iliopsoas muscle. He was first treated with cytarabine, then treatment was switched to a combination of steroids and dasatinib after the final diagnosis. The blast in peripheral blood disappeared, and the mass in the left iliopsoas shrunk one month after dasatinib treatment. Later bone marrow biopsy findings confirmed initial bone marrow necrosis. Although EMD associated with bone marrow necrosis at disease onset of MPAL with minor BCR/ABL is rare, our case underscores that no type of leukemia should be excluded from the differential diagnosis of bone marrow necrosis and EMD.

Zitieren

APA

Shimazu, Y., Miyoshi, T., Mibayashi, S., Kazuma, Y., Kobayashi, M., Shindo, K., & Imashuku, S. (2023). Extramedullary Disease with Bone Marrow Necrosis at Disease Onset in A Case of Mixed Phenotypic Acute Leukemia with BCR::ABL1 Fusion Gene: a Case Report and Review of the Literature. Oncology Advances. https://doi.org/10.14218/ona.2023.00022

Vancouver

Shimazu Y, Miyoshi T, Mibayashi S, Kazuma Y, Kobayashi M, Shindo K, et al. Extramedullary Disease with Bone Marrow Necrosis at Disease Onset in A Case of Mixed Phenotypic Acute Leukemia with BCR::ABL1 Fusion Gene: a Case Report and Review of the Literature. Oncology Advances. 2023. doi:10.14218/ona.2023.00022

BibTeX
@article{Shimazu2023,
  author = {Shimazu, Yutaka and Miyoshi, Takashi and Mibayashi, Satoko and Kazuma, Yasuhiro and Kobayashi, Miyako and Shindo, Keisuke and Imashuku, Shinsaku},
  title = {Extramedullary Disease with Bone Marrow Necrosis at Disease Onset in A Case of Mixed Phenotypic Acute Leukemia with BCR::ABL1 Fusion Gene: a Case Report and Review of the Literature},
  journal = {Oncology Advances},
  year = {2023},
  doi = {10.14218/ona.2023.00022}
}
Kostenlos starten →